Orbital metastasis revealing an undifferenciated Carcinoma of nasopharyngeal type: a case report

##plugins.themes.academic_pro.article.sidebar##

Published Aug 2, 2016
Download
pdf
Vol. 94 No. 2 (2016): Issue Feb 2016

##plugins.themes.academic_pro.article.main##

Senda Turki
Ali Mardassi
Maher Abouda
Amani Hachicha
Wady Ben Jallel

Abstract

Summary:
The evolution of the undifferentiated carcinoma of the nasopharynx (NPC) is marked by the occurrence of regional or distant metastasis. We report a rare observation of bilateral orbital metastasis of NPC. Clinical symptoms were ocular proptosis, blurred vision and eye redness. Imaging permitted to precise the extensions of the tumor which was classified T4N1M1 after clinical and paraclinical exams. The treatment consisted of concomitant radiochemotherapy. The evolution didn’t revealed recurrence of the disease after 18 months. 

Keywords:

undifferentiated carcinoma of the nasopharynx, orbital metastasis, imaging, radiochemotherapy.

##plugins.themes.academic_pro.article.details##

References

  1. Wided BA, Hamouda B, Hamadi H, Mansour BA. Nasopharyngeal carcinoma incidence in North Tunisia: negative trends in adults but not adolescents, 1994-2006. AsianPac J Cancer Prev. 2015;16(7):2653-7.
  2. Fleury B, Biston MC, Montbarbon X, Pommier P. Cancers du cavum de l'adulte. Cancer/Radiothérapie. 2010; 14:S23-S33.
  3. Djemaa-Bendjazia A, Sahli B, Bali MS. Chimiothérapie d'induction par docétaxel,cisplatine et 5-fluoro-uracile (TPF) suivie dechimioradiothérapie concomitante dans le cancerducavum localement évolué non métastatique, Ã propos de 25 cas. Cancer/Radiothérapie.2012 ;16 :524-81.
  4. Altun M, Tenekeci N, Kaytan E, Meral R. Locally advanced nasopharyngeal carcinoma: computed tomography findings, clinical evaluation, and treatment outcome. Int. J. Radiation Oncology Biol. Phys. 2000;47 (2):401-4.
  5. Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, Morrison WH et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int. J. Radiation Oncology Biol. Phys. 1997;37 (5):985-96.
  6. Hsu WM1, Wang AG. Nasopharyngeal carcinoma with orbital invasion.Eye.2004 ;18(8):833-8.
  7. Ching ASC, Chong VFH, Khoo JBK. CT Evaluation of Nasolacrimal Relapse of Nasopharyngeal Carcinoma.Clinical Radiology. 2003;58:642-7.
  8. Klauss V, ChanaH.Ocular tumors in Africa. Sot. Sci. Med. 1983;17 (22):1743-50.
  9. Zhang H, Yan JH, Wu ZY, Li YP.Clinical analysis of orbital metastasis from nasopharyngeal carcinoma.2006 ;42(4):318-22. Chinese.
  10. Lai V, PekLanKhong PL. Updates on MR imaging and 18F-FDG PET/CT imaging in nasopharyngealcarcinoma. Oral Oncology. 2014;50:539-48.
  11. Chang JTC, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Int. J. Radiation OncologyBiol. Phys. 2005;63 (5):1354-60.
  12. Marcy PY, Zhu Y, Bensadoun RJ. Volumes cibles en radiothérapie des tumeurs de la tête et du cou Radiothérapie conformationnelle avec modulation d'intensité (RCMI) des carcinomes du cavum : aspects pratiques de la délinéation des volumes cibles et des organes critiques. Cancer/Radiothérapie.2005 ;9 :240-50.
  13. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J RadiatOncolBiol Phys. 2003;57:481-8.
  14. Amrith S.Antero-medialorbital masses associatedwithnasopharyngealcarcinoma. Singapore Med J. 2002 ;43(2):097-9. 15) Noël G, Dessard-Diana B, Vignot S, Mazeron JJ. Les traitements des cancers du nasopharynx : revue de la littérature. Cancer/Radiother. 2002;6:59-84.
  15. Kochbati L, Essaidi I, Labidi M, Yahiaoui S, Ben Salem L, Nasr C et al. Évaluation des doses de tolérance des organes à risque après radiothérapie bidimensionnelle des cancers du nasopharynx classés T4 chez les sujets jeunes. Cancer/Radiothérapie. 2012 ;16 :524-81.
  16. Kochbati L, Essaidi I, Labidi M, Yahiaoui S, Ben Salem L, Nasr C et al. Évaluation des doses de tolérance des organes à risque après radiothérapie bidimensionnelle des cancers du nasopharynx classés T4 chez les sujets jeunes. Cancer/Radiothérapie. 2012 ;16 :524-81.
  17. Wee CW, Keam B, Heo DS, Sung MW, Won TB, Wu HG. Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy. RadiatOncol J. 2015;33(2):98-108.